top of page

Sunday 7th December

Challanges & perspectives in Nephrology

3WSHT_edited.jpg
ΕΝΙΝ_Πρόταση_2_edited.jpg

Update in Nephrology

Quality of Care and patient safety

Q&S_edited.jpg

S.1. Quality of Care and patient safety: principles

  1. The role of standards and patient safety indicators         

  2The role of the Renal registries  

  3. The importance of staff training, competence and                  revalidation

  4. Empowering patients to get their voice heard

S.2. Quality of Care and patient safety: policies

  1. The CQC standards and policies for Dialysis Units

  2. The UKKA KQI Program   

  3. The Greek national policy

  4. The paradigm of Dialysis providers

Workshop on home therapies

3WSHTs-FINAL_edited.jpg

S.3. Healthcare systems & policies

  1. Achieving equity in dialysis care and outcomes:

      the role of policies

  2. System-Level Strategies to Improve Home Dialysis

S.4. Quality of life

  1. Patient reported experience and outcome measures

  2. Burden of treatment, social engagement and

      employment across different modalities

S.5. Clinical outcomes

  1.Cardiovascular outcomes across different modalities

  2. The role of networks and the interdisciplinary team

Hands-on training

CH25-PRAKTIKH_2_edited.jpg

K.1. US guided AV fistula needling

K.2. e-Poster session

General assembly & elections

Κ.8. Hypertension

  1. Guidelines on hypertension in CKD patients 

  2. Clinical trial update on hypertension

S.7. Nursing session

  1. Haemodialysis protocols

  2. EDTNA accreditation of nursing training

  3. Dry weight assessment

Κ.4. Cardio-renal-metabolic syndrome

  1. SGLT2 inhibitors: update  
  2. The place of GLP-1 agonists in clinical practice

  3. The place of MRAs in clinical practice

Κ.5. Cardiovascular morbidity in CKD 

  1. Treatment on hyperlipidaemia: what's new?

  2. Challenges in the treatment of heart failure

Κ.3. What's new in heamodialysis?

  1. Uraemic pruritus: systemic screening and assessment in view of the novel therapies

  2. IDPN: when, to whom, and how?

  3. HIF inhibitors: their place in clinical practice

  4. Treatment of hyperparathyroidism

Conclusions

Close

Κ.7. Clinical Nephrology

  1. Novel & emerging treatments in IgA nephropathy

  2. How to treat the patient with IgA nephropathy?

​​K.6. Hereditary nephropathies

1. ADPKD: The importance of the total kidney volume          (TKV) - new data and applications

2. Fabry disease: what should I know?

Close

bottom of page